PMID- 8642785 OWN - NLM STAT- MEDLINE DCOM- 19960716 LR - 20220321 IS - 0023-6837 (Print) IS - 0023-6837 (Linking) VI - 74 IP - 5 DP - 1996 May TI - Osteogenic potential of murine osteosarcoma cells: comparison of bone-specific gene expression in in vitro and in vivo conditions. PG - 895-906 AB - Bone tissue formation and the expression of osteoblast-specific genes were compared in vitro and in vivo for two well characterized murine clonal osteosarcoma cell lines (K7 and K8). In vitro studies were carried out under conditions that promoted extracellular matrix morphogenesis and mineralization. The K8 cells showed 8-fold greater alkaline phosphatase activity and mineral accumulation than did K7 cells during 21 days of in vitro growth. The K8 cell line showed high levels of bone sialoprotein (BSP), collagen type I (COL I), and alkaline phosphatase (APase) mRNA expression throughout its growth in vitro. In contrast, K7 cells showed an almost complete absence of BSP and COL I and very low levels of APase throughout the culture period. In vitro, both cell lines expressed very low levels of osteocalcin (OC). For in vivo studies, we used a three-dimensional culture device that permitted analysis of tissue formation by the cells after their implantation into syngeneic mice. The K8 cells consistently generated extensive mineralized woven bone after their subcutaneous implantation. The striking features distinguishing the bone formed by the implanted cells from normal recipient bone were the complete absence of osteoclasts or matrix resorption, the absence of OC protein, and very low levels of OC mRNA expression in the tissues formed by these cell lines. BSP, APase, and COL I expressions were maintained at high levels in the K8-produced tissues. In contrast to their near absence in vitro, APase, BSP, and COL I were expressed by K7 cells and increased with time in vivo. These findings demonstrate that the K7 cells in vitro are less differentiated than K8 cells, but that K7 cells in vivo undergo osteogenic maturation. Thus, expression of bone-specific genes in these osteogenic cell lines was dependent on systemic or local factors in recipient animals and was distinct for these cell lines when grown under in vitro conditions. OC protein does not appear to be needed for the mineralization of the extracellular matrix but may be needed to provide the necessary signals for the resorption and remodeling of the tissue. FAU - Gerstenfeld, L C AU - Gerstenfeld LC AD - Laboratory for the Study of Skeletal Disorders and Rehabilitation, Children's Hospital, Boston, Massachusetts 02115, USA. FAU - Uporova, T AU - Uporova T FAU - Schmidt, J AU - Schmidt J FAU - Strauss, P G AU - Strauss PG FAU - Shih, S D AU - Shih SD FAU - Huang, L F AU - Huang LF FAU - Gundberg, C AU - Gundberg C FAU - Mizuno, S AU - Mizuno S FAU - Glowacki, J AU - Glowacki J LA - eng GR - P01 AR 34078/AR/NIAMS NIH HHS/United States GR - R01 AR 43434/AR/NIAMS NIH HHS/United States GR - R01 DE 08798/DE/NIDCR NIH HHS/United States PT - Comparative Study PT - Journal Article PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Lab Invest JT - Laboratory investigation; a journal of technical methods and pathology JID - 0376617 RN - 0 (Sialoglycoproteins) RN - 0 (Spp1 protein, mouse) RN - 104982-03-8 (Osteocalcin) RN - 106441-73-0 (Osteopontin) RN - 63231-63-0 (RNA) RN - 9007-34-5 (Collagen) RN - EC 3.1.3.1 (Alkaline Phosphatase) RN - SY7Q814VUP (Calcium) SB - IM MH - Alkaline Phosphatase/genetics MH - Animals MH - Bone Matrix/metabolism MH - Bone Neoplasms/genetics/*metabolism/pathology MH - Calcification, Physiologic MH - Calcium/analysis MH - Collagen/genetics MH - Electrophoresis, Agar Gel MH - *Gene Expression MH - Mice MH - Mice, Inbred BALB C MH - Neoplasm Transplantation MH - Osteoblasts/*cytology/metabolism MH - Osteocalcin/analysis/genetics MH - *Osteogenesis MH - Osteopontin MH - Osteosarcoma/genetics/*metabolism/pathology MH - RNA/analysis/genetics MH - Sialoglycoproteins/genetics MH - Tumor Cells, Cultured EDAT- 1996/05/01 00:00 MHDA- 1996/05/01 00:01 CRDT- 1996/05/01 00:00 PHST- 1996/05/01 00:00 [pubmed] PHST- 1996/05/01 00:01 [medline] PHST- 1996/05/01 00:00 [entrez] PST - ppublish SO - Lab Invest. 1996 May;74(5):895-906.